Schedule 13D ownership disclosure

ITERUM THERAPEUTICS PLC SHS NEW

Security class unavailable · CUSIP: G6333L101

Event date: 2020-01-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
868,161
Percent of class
5.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001062993-20-000379
Form type
SC 13D/A
Filer
Advent Life Sciences LLP
CIK
CIK 1601364
Filed
Jan 29, 2020
Reporting period
Jan 16, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub